Interestingly, our meta-analysis incorporating the study by Jiang et al. suggested that TPI1 may act as a suppressor of HCC progression, which appears inconsistent with our bioinformatics findings indicating that TPI1 upregulation is associated with poor prognosis. This evidence concerns the gene TPI1 and hepatocellular carcinoma.